7 Scleroderma Headlines

0
(0)

6 – New Cannabinoid-based Drug Slows Fibrosis, Blocks Inflammation in Early Scleroderma Study

news_12_scleroderma copy

A research team has developed a cannabinoid-based drug which stimulates not only one, but two, receptors believed to be involved in fibrosis development in scleroderma. The drug, VCE-004.8, prevented the formation of fibrosis-promoting myofibroblasts in culture and stopped fibrotic changes in a mouse model of dermal fibrosis. Findings from these pre-clinical studies, while early, are promising and may lead to a new therapy for SSc.

Read full article here: http://bit.ly/1RnyvuL

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *